Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
55 GBX | +5.77% | +4.76% | -11.29% |
13/05 | HC Wainwright Adjusts Price Target on Verona Pharma to $30 From $32, Maintains Buy Rating | MT |
09/05 | Verona Pharma Signs Financing Agreements for Up to $650 Million | MT |
- Stock Market
- Equities
- VRNA Stock
- VRP Stock
- News Verona Pharma plc
- MarketScreener Editorial Features